Finance

Lists
002720:KRX
Kukje Pharma Co Ltd
â‚©3,415.00
+0.89%
(+30.00) 1D
Sep 4, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 002720...
Open
â‚©3,415
High
â‚©3,430
Low
â‚©3,355
Mkt. cap
72.26B
Avg. vol.
88.30K
Volume
25.40K
Dividend
0.88%
Quarterly dividend
â‚©8
Ex-dividend date
Mar 12, 2026
P/E ratio
14.31
52-wk high
â‚©5,470
52-wk low
â‚©2,810
EPS
â‚©239
Shares outstanding
21.16M
No. of employees
248
Open
â‚©3,415
High
â‚©3,430
Low
â‚©3,355
Mkt. cap
72.26B
Avg. vol.
88.30K
Volume
25.40K
Dividend
0.88%
Quarterly dividend
â‚©8
Ex-dividend date
Mar 12, 2026
P/E ratio
14.31
52-wk high
â‚©5,470
52-wk low
â‚©2,810
EPS
â‚©239
Shares outstanding
21.16M
No. of employees
248
About Kukje Pharma Co Ltd
CEO-
Employees248
Founded1959
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
45.63B
43.34B
43.98B
48.32B
Cost of goods sold
20.70B
21.74B
20.17B
21.41B
Cost of revenue
20.70B
21.74B
20.17B
21.41B
Research and development expenses
658.59M
1.79B
931.78M
1.34B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22.13B
21.36B
20.66B
23.05B
Operating expense
23.02B
23.14B
21.85B
24.77B
Total operating expenses
43.72B
44.88B
42.01B
46.18B
Operating income
1.92B
-1.54B
1.97B
2.13B
Other non operating income
392.85M
195.68M
199.95M
268.92M
EBT including unusual items
2.42B
-1.54B
2.62B
2.18B
EBT excluding unusual items
2.41B
-1.34B
2.60B
2.23B
Income tax expense
505.72M
-808.40M
477.03M
513.17M
Effective tax rate
20.87%
52.36%
18.20%
23.54%
Other operating expenses
-
-
-
-
Net income
1.91B
-731.53M
2.15B
1.67B
Net profit margin
4.19%
-1.69%
4.88%
3.46%
Earnings per share
-
-
-
-
Interest and investment income
139.49M
130.84M
77.28M
83.58M
Interest expense
-218.61M
-198.95M
-188.96M
-195.74M
Net interest expenses
-79.12M
-68.10M
-111.69M
-112.16M
Depreciation and amortization charges
167.22M
161.54M
168.12M
197.45M
EBITDA
2.73B
-723.71M
2.81B
3.02B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps